Consolidated statement of recognised income and expense
for the years ended 31 March
| Note | 2009 £m |
2008 £m |
Restated 2007 £m |
|
|---|---|---|---|---|
| (Losses)/gains on revaluation of available-for-sale investments, net of tax | 22 | (2,383) | 1,949 | 2,108 |
| Exchange differences on translation of foreign operations, net of tax | 22 | 12,375 | 5,537 | (3,804) |
| Net actuarial (losses)/gains on defined benefit pension schemes, net of tax | 22 | (163) | (37) | 50 |
| Revaluation gain | 22 | 68 | – | – |
| Foreign exchange (gains)/losses transferred to the consolidated income statement | 22 | (3) | (7) | 763 |
| Fair value gains transferred to the consolidated income statement | 22 | – | (570) | – |
| Other, net of tax | 22 | (40) | 37 | – |
| Net gain/(loss) recognised directly in equity | 9,854 | 6,909 | (883) | |
| Profit/(loss) for the financial year | 3,080 | 6,756 | (5,222) | |
| Total recognised income and expense relating to the year | 12,934 | 13,665 | (6,105) | |
| Attributable to: | ||||
| – Equity shareholders | 13,037 | 13,912 | (6,210) | |
| – Minority interests | (103) | (247) | 105 | |
| 12,934 | 13,665 | (6,105) |
The accompanying notes are an integral part of these consolidated financial statements.